CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins.

Saved in:
Bibliographic Details
Title: CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins.
Authors: Wang Y, Reshetnikova E, Katuwal NB, Bharti V, Pereira MSF, Oppong BA, Lee D, Mittra A, Freud AG, Vilgelm AE
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Apr 22. Date of Electronic Publication: 2026 Apr 22.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.04.19.719504